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Background: In patients with Hypertrophic Cardiomyopathy (HCM), pathogenic mutations in myosin binding protein-C (MYBPC3) are thought to be 
associated with lesser hypertrophy and later onset of disease compared to beta-myosin heavy chain (MYH7) mutations. We assessed whether there 
were differences in disease expression by cardiovascular magnetic resonance imaging (CMR) in a large HCM population comparing patients with 
MYBPC3 and MYH7 mutations.
methods: CMR was performed on 338 genotyped HCM patients (maximal wall thickness ≥15mm) to assess disease morphology. Only patients with 
single pathogenic mutations in MYBPC3 or MYH7 genes were included. Demographic and clinical information was also collected.
results: Pathogenic sarcomere protein gene mutations were present in 140 (41%) patients, with MYBPC3 mutations found in 56 (40%) and MYH7 
mutations in 52 (37%). Clinical characteristics including age were similar as were risk factors for sudden cardiac death. In addition there were no 
differences in CMR derived maximal wall thickness, left ventricular mass, presence and extent of myocardial fibrosis as well as septal morphology 
(Table).
conclusions: This data does not support any phenotypic differences among HCM patients carrying a MYBPC3 mutation compared to patients 
carrying a MYH7 mutation. 
